US and Chennai-based Twin Health, makers of the Whole Body Digital Twin precision health technology, has announced Rs 1000 Cr in Series C funding as it scales its presence in India and the US.

The funds will help to scale Whole Body Digital Twin technology to reverse and prevent chronic metabolic diseases, including type 2 diabetes.

The Whole Body Digital Twin provides guidance to nutrition, sleep, activity and meditative breathing to patients and their doctors to safely reverse and prevent a variety of chronic metabolic diseases, including type 2 diabetes, cardiovascular disease and liver disease.

Prof Shashank Joshi, Chief Scientist at Twin Health, Consultant Endocrinologist Lilavati Hospital Mumbai and President of Indian Academy of Diabetes said, “As a scientist, I am impressed by the ongoing RCT results and the cutting edge Whole Body Digital Twin technology. Now, it has been scientifically proven that Type 2 Diabetes can be reversed by healing the root cause of chronic metabolic diseases including type 2 diabetes with highly personalised data-driven recommendations to doctors and patients.”